Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial

OBJECTIVE—To assess the efficacy and safety of sulphasalazine in reactive arthritis.
METHODS—Double blind placebo controlled trial of six months duration comparing sulphasalazine 2-3 g per day (n = 37) with matching placebo (n = 42) in adults with active reactive arthritis (age 19-57 years, median 3...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Egsmose, C., Hansen, T. M., Andersen, L. S., Beier, J. M., Christensen, L., Ejstrup, L., Peters, N. D., van der Heijde, D. M F M
Format: Artigo
Jezik:Inglês
Izdano: 1997
Teme:
Extended Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1752243/
https://ncbi.nlm.nih.gov/pubmed/9059138
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki